Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Read more about Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. Read more about The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia. Read more about Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia.
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Read more about Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit. Read more about Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis. Read more about Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis.
Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID. Read more about Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID.
Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies. Read more about Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies.
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia. Read more about Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia.
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. Read more about Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.
